Vericel (VCEL) EBT Growth (5y) (2015 - 2026)
Powered by 
Analysis
Vericel (VCEL) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.55 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.99 Bn | 1.99 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.06% |
| Mar 31, 2026 | -15.16% |
| Dec 31, 2025 | 14.25% |
| Sep 30, 2025 | 7.11% |
| Jun 30, 2025 | 42.30% |
| Mar 31, 2025 | -19.13% |
| Dec 31, 2024 | 15.93% |
| Sep 30, 2024 | -17.70% |
| Jun 30, 2024 | 25.06% |
| Mar 31, 2024 | -6.01% |
| Dec 31, 2023 | 12.53% |
| Sep 30, 2023 | -21.52% |
| Jun 30, 2023 | -1.69% |
| Mar 31, 2023 | -9.50% |
| Dec 31, 2022 | 27.25% |
| Sep 30, 2022 | -8.57% |
| Jun 30, 2022 | -26.05% |
| Mar 31, 2022 | 6.43% |
| Dec 31, 2021 | 27.10% |
| Sep 30, 2021 | 5.28% |